S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
What to Expect from the Markets in a Recession
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
pixel
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Bangladesh seeks China help to repatriate Rohingya refugees
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
What to Expect from the Markets in a Recession
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
pixel
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Bangladesh seeks China help to repatriate Rohingya refugees
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
What to Expect from the Markets in a Recession
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
pixel
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Bangladesh seeks China help to repatriate Rohingya refugees
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
pixel
What to Expect from the Markets in a Recession
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
pixel
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Bangladesh seeks China help to repatriate Rohingya refugees
NASDAQ:HSIC

Henry Schein - HSIC Stock Forecast, Price & News

$75.38
+1.23 (+1.66%)
(As of 08/5/2022 08:48 PM ET)
Add
Compare
Today's Range
$73.56
$75.47
50-Day Range
$73.17
$85.96
52-Week Range
$70.25
$92.68
Volume
659,600 shs
Average Volume
927,005 shs
Market Capitalization
$10.26 billion
P/E Ratio
16.18
Dividend Yield
N/A
Price Target
$87.14

Henry Schein MarketRank™ Forecast

Analyst Rating
Hold
2.29 Rating Score
Upside/​Downside
15.6% Upside
$87.14 Price Target
Short Interest
Bearish
3.00% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.99
Upright™ Environmental Score
News Sentiment
-0.23mentions of Henry Schein in the last 14 days
Based on 44 Articles This Week
Insider Trading
Selling Shares
$981,965 Sold Last Quarter
Proj. Earnings Growth
6.60%
From $4.85 to $5.17 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.97 out of 5 stars

Medical Sector

735th out of 1,283 stocks

Medical & Hospital Equipment Industry

3rd out of 3 stocks

HSIC stock logo

About Henry Schein (NASDAQ:HSIC) Stock

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. Piper Sandler reduced their price target on Henry Schein from $100.00 to $96.00 in a research report on Tuesday, August 2nd. StockNews.com cut Henry Schein from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, July 19th. Credit Suisse Group reduced their price objective on shares of Henry Schein from $100.00 to $90.00 and set an "outperform" rating for the company in a research note on Wednesday. Robert W. Baird lowered shares of Henry Schein from an "outperform" rating to a "neutral" rating and decreased their target price for the stock from $103.00 to $88.00 in a report on Tuesday, June 14th. Finally, Barrington Research reduced their price target on shares of Henry Schein from $102.00 to $99.00 and set an "outperform" rating for the company in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $87.14.

Henry Schein Price Performance

Shares of NASDAQ:HSIC traded up $1.23 during trading on Friday, reaching $75.38. The company had a trading volume of 659,650 shares, compared to its average volume of 765,484. The company has a fifty day moving average of $77.98 and a two-hundred day moving average of $82.02. The company has a current ratio of 1.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.18. The stock has a market capitalization of $10.26 billion, a P/E ratio of 16.18, a price-to-earnings-growth ratio of 2.03 and a beta of 0.75. Henry Schein has a 12 month low of $70.25 and a 12 month high of $92.68.

Henry Schein (NASDAQ:HSIC - Get Rating) last posted its quarterly earnings results on Tuesday, August 2nd. The company reported $1.16 earnings per share for the quarter, hitting the consensus estimate of $1.16. The business had revenue of $3.03 billion during the quarter, compared to the consensus estimate of $3.12 billion. Henry Schein had a net margin of 5.11% and a return on equity of 15.56%. The firm's revenue for the quarter was up 2.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.11 earnings per share. Equities research analysts forecast that Henry Schein will post 4.85 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP Gerald A. Benjamin sold 11,489 shares of the business's stock in a transaction dated Thursday, May 26th. The shares were sold at an average price of $85.47, for a total transaction of $981,964.83. Following the sale, the executive vice president now owns 95,616 shares of the company's stock, valued at $8,172,299.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.00% of the stock is owned by insiders.

Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

HSIC Stock News Headlines

Henry Schein (HSIC) Q2 2022 Earnings Call Transcript
Analyst Ratings for Henry Schein
See More Headlines
Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

HSIC Company Calendar

Last Earnings
8/02/2022
Today
8/07/2022
Next Earnings (Estimated)
11/01/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Medical & hospital equipment
Sub-Industry
Health Care Distributors
Sector
Medical
Current Symbol
NASDAQ:HSIC
CUSIP
80640710
Employees
21,600
Year Founded
1932

Price Target and Rating

Average Stock Price Forecast
$87.14
High Stock Price Forecast
$99.00
Low Stock Price Forecast
$72.00
Forecasted Upside/Downside
+15.6%
Consensus Rating
Hold
Rating Score (0-4)
2.29
Research Coverage
7 Analysts

Profitability

Net Income
$631.23 million
Pretax Margin
6.70%

Debt

Sales & Book Value

Annual Sales
$12.40 billion
Cash Flow
$6.13 per share
Book Value
$31.06 per share

Miscellaneous

Free Float
134,754,000
Market Cap
$10.26 billion
Optionable
Optionable
Beta
0.75

Social Links















HSIC Stock - Frequently Asked Questions

Should I buy or sell Henry Schein stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Henry Schein stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HSIC, but not buy additional shares or sell existing shares.
View analyst ratings for Henry Schein
or view top-rated stocks.

What is Henry Schein's stock price forecast for 2022?

7 analysts have issued 1-year price targets for Henry Schein's stock. Their HSIC stock forecasts range from $72.00 to $99.00. On average, they expect Henry Schein's share price to reach $87.14 in the next twelve months. This suggests a possible upside of 15.6% from the stock's current price.
View analysts' price targets for Henry Schein
or view top-rated stocks among Wall Street analysts.

How has Henry Schein's stock price performed in 2022?

Henry Schein's stock was trading at $77.53 at the start of the year. Since then, HSIC stock has decreased by 2.8% and is now trading at $75.38.
View the best growth stocks for 2022 here
.

When is Henry Schein's next earnings date?

Henry Schein is scheduled to release its next quarterly earnings announcement on Tuesday, November 1st 2022.
View our earnings forecast for Henry Schein
.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) posted its quarterly earnings data on Tuesday, August, 2nd. The company reported $1.16 earnings per share for the quarter, meeting analysts' consensus estimates of $1.16. The business earned $3.03 billion during the quarter, compared to analyst estimates of $3.12 billion. Henry Schein had a trailing twelve-month return on equity of 15.56% and a net margin of 5.11%. The firm's revenue was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.11 earnings per share.
Read Henry Schein's conference call transcript
.

When did Henry Schein's stock split? How did Henry Schein's stock split work?

Shares of Henry Schein split on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly minted shares were distributed to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein declared that its Board of Directors has authorized a share buyback program on Thursday, May 13th 2021, which permits the company to buyback $400,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to buy up to 3.6% of its stock through open market purchases. Stock buyback programs are usually an indication that the company's board of directors believes its stock is undervalued.

What guidance has Henry Schein issued on next quarter's earnings?

Henry Schein issued an update on its FY 2022 earnings guidance on Tuesday, August, 2nd. The company provided EPS guidance of $4.75-$4.91 for the period, compared to the consensus estimate of $4.86. The company issued revenue guidance of $12.77 billion-$13.14 billion, compared to the consensus revenue estimate of $13.05 billion.

What is Stanley M. Bergman's approval rating as Henry Schein's CEO?

451 employees have rated Henry Schein CEO Stanley M. Bergman on Glassdoor.com. Stanley M. Bergman has an approval rating of 94% among Henry Schein's employees. This puts Stanley M. Bergman in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Henry Schein own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM), CVS Health (CVS), Micron Technology (MU) and AT&T (T).

What is Henry Schein's stock symbol?

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

Who are Henry Schein's major shareholders?

Henry Schein's stock is owned by many different retail and institutional investors. Top institutional shareholders include Pendal Group Ltd (2.54%), Ardevora Asset Management LLP (0.52%), Marathon Asset Management Ltd (0.51%), DekaBank Deutsche Girozentrale (0.47%), Boston Trust Walden Corp (0.40%) and Pzena Investment Management LLC (0.37%). Company insiders that own Henry Schein stock include Deborah Derby, Gerald A Benjamin, James P Breslawski, James P Breslawski, Kurt P Kuehn, Mark E Mlotek, Michael S Ettinger, Paul Brons, Scott Philip Serota, Stanley M Bergman, Steven Paladino and Walter Siegel.
View institutional ownership trends for Henry Schein
.

How do I buy shares of Henry Schein?

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Henry Schein's stock price today?

One share of HSIC stock can currently be purchased for approximately $75.38.

How much money does Henry Schein make?

Henry Schein (NASDAQ:HSIC) has a market capitalization of $10.26 billion and generates $12.40 billion in revenue each year. The company earns $631.23 million in net income (profit) each year or $4.66 on an earnings per share basis.

How many employees does Henry Schein have?

Henry Schein employs 21,600 workers across the globe.

Does Henry Schein have any subsidiaries?

The following companies are subsidiares of Henry Schein: ACE Surgical Supply Co., ADS Florida, AUV Veterinary Services, Accord, Alpha Scientific, Arcade Dentaire, Arseus, Arseus Dental Solutions, Arseus Lab, Becker-Parkin Dental Supply, BioHorizons Inc., Butler Schein Animal Health, C&M Vetlink, Camlog USA Inc., DNA Anthos Impianti, Dental Cremer, Dental Trey, Elite Computer Italia, Exan Enterprises Inc., General Injectables & Vaccines Inc., HS Brand Management Inc., HS TM Holdings LLC, Handpiece Parts & Repairs Inc., Henry Schein Europe Inc., Henry Schein Latin America Pacific Rim Inc., Henry Schein Medical Systems Inc., Henry Schein Practice Solutions Inc., Jorgen Kruuse, Lincoln Dental Supply, Logiciel Julie, Maddox Practice Group, Maravet, Marrodent, Medivet, Medka, Minerva Dental Limited, Modern Laboratory Services, NLS Animal Health, Noviko, Ortho Organizers, Ortho Technology, Project Helium Holdings LLC, Project Spartan Holdings Corp., RxWorks, SG Healthcare Corp, Sirona Direct, SmartPak Equine LLC, Software of Excellence, Sogim Grimouille, Southern Anesthesia & Surgical, The Exan Group, Veterinary Instrumentation, Vetstreet, W. & J. Dunlop, and scil animal care.
Read More

When was Henry Schein founded?

Henry Schein was founded in 1932.

How can I contact Henry Schein?

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The official website for Henry Schein is www.henryschein.com. The company can be reached via phone at (631) 843-5500, via email at steven.paladino@henryschein.com, or via fax at 631-843-5541.

This page (NASDAQ:HSIC) was last updated on 8/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.